7
6-Chloro-4-phenyl-3-(trifluoromethyl)-2H-chromen-2-one
(s), 116.83 (t, J = 22.9 Hz), 111.93 (t, J = 252.8 Hz), 63.17 (s),
ACCEPTED MANUSCRIPT
(6e, CAS: 2242965-75-7) 11(e). White solid (33.0 mg, 48%). H
21.72 (s), 13.81 (s). 19F NMR (377 MHz, CDCl3) δ -98.04 (s).
1
NMR (500 MHz, CDCl3) δ 7.59 – 7.51 (m, 1H), 7.41 (d, J = 1.9
Hz, 1H), 7.24 (dd, J = 6.5, 2.9 Hz, 1H), 7.17 (dd, J = 8.7, 1.9 Hz,
1H), 6.95 (d, J = 8.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ
156.27 (d, J = 2.0 Hz), 155.71 (s), 153.61 (s), 140.38 (s), 132.44
(s), 130.22 (s), 129.56 (s), 128.66 (s), 127.21 (d, J = 1.5 Hz),
125.47 (s), 121.71 (q, J = 275.3 Hz), 118.14 (s), 117.06 (s),
114.93 (q, J = 30.4 Hz). 19F NMR (377 MHz, CDCl3) δ -57.95 (s).
HRMS (ESI) m/z: [M+Na]+ Calcd. For C16H8ClF3O2Na 347.0063;
found 347.0056.
GC–MS (EI, m/z): 358.10.
Ethyl
2-(6-tert-butyl-2-oxo-4-phenyl-2H-chromen-3-yl)-
2,2-difluoroacetate (7c, CAS: 1699735-62-0)13. White solid
1
(68.1 mg, 82%). H NMR (500 MHz, CDCl3) δ 7.52 – 7.46 (m,
3H), 7.41 (d, J = 1.8 Hz, 1H), 7.31 (dd, J = 6.6, 3.0 Hz, 2H), 7.25
(dd, J = 8.6, 1.9 Hz, 1H), 7.00 (d, J = 8.5 Hz, 1H), 4.34 (q, J =
7.1 Hz, 2H), 1.34 (s, 9H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (126
MHz, CDCl3) δ 162.81 (t, J = 32.3 Hz), 159.36 (t, J = 4.5 Hz),
158.38 (s), 156.01 (s), 153.22 (s), 133.12 (s), 128.95 (s), 128.41
(s), 128.19 (s), 127.59 (t, J = 2.2 Hz), 122.43 (s), 117.71 (s),
117.04 (t, J = 23.0 Hz), 113.65 (s), 111.93 (t, J = 252.7 Hz),
63.15 (s), 35.37 (s), 30.91 (s), 13.82 (s). 19F NMR (377 MHz,
CDCl3) δ -98.12 (s). GC–MS (EI, m/z): 400.15.
6-Bromo-4-phenyl-3-(trifluoromethyl)-2H-chromen-2-one
1
(6f, CAS: 2242965-76-8)11(e). White solid (33.8 mg, 43%). H
NMR (500 MHz, CDCl3) δ 7.71 (dd, J = 8.8, 2.3 Hz, 1H), 7.56
(dd, J = 4.9, 1.8 Hz, 3H), 7.30 (d, J = 8.8 Hz, 1H), 7.25 (dd, J =
6.4, 3.1 Hz, 2H), 7.10 (d, J = 2.2 Hz, 1H). 13C NMR (126 MHz,
CDCl3) δ 155.75 (d, J = 2.2 Hz), 155.61 (s), 152.30 (s), 136.91
(s), 132.04 (s), 131.40 (s), 129.72 (s), 128.76 (s), 127.22 (s),
121.57 (q, J = 276.1 Hz), 121.08 (s), 118.63 (s), 117.65 (s),
116.04 (q, J = 30.8 Hz). 19F NMR (377 MHz, CDCl3) δ -58.08 (s).
HRMS (ESI) m/z: [M+Na]+ Calcd. For C16H8BrF3O2Na 390.9557;
found 390.9563.
Ethyl
2,2-difluoro-2-(7-methoxy-2-oxo-4-phenyl-2H-
chromen-3-yl)acetate (7d). White solid (60.8 mg, 80%).1H
NMR (500 MHz, CDCl3) δ 7.51 (dd, J = 5.0, 1.7 Hz, 3H), 7.35
(d, J = 9.0 Hz, 1H), 7.32 (dd, J = 6.5, 3.1 Hz, 2H), 7.18 (dd, J =
9.0, 3.0 Hz, 1H), 6.47 (d, J = 2.9 Hz, 1H), 4.35 (q, J = 7.1 Hz,
2H), 3.65 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz,
CDCl3) δ 162.77 (t, J = 32.2 Hz), 159.15 (t, J = 4.5 Hz), 156.21
(s), 155.79 (s), 147.58 (s), 132.90 (s), 129.10 (s), 128.30 (s),
127.53 (t, J = 2.3 Hz), 120.70 (s), 120.65 (s), 118.30 (t, J = 22.9
Hz), 117.87 (s), 111.83 (t, J = 253.1 Hz), 111.42 (s), 63.23 (s),
55.69 (s), 13.82 (s). IR (cm-1): ν 2937, 1793, 1741, 1627, 1371,
1160, 1090. 19F NMR (377 MHz, CDCl3) δ -98.36 (s). HRMS
(ESI) m/z: [M+Na]+ Calcd. For C20H19F2O5Na 397.0863; found
397.0876.
4-(4-Methoxyphenyl)-3-(trifluoromethyl)-2H-chromen-2-
one (6g, CAS: 1621190-90-6)12,15. White solid (34.4 mg, 51%).
1H NMR (500 MHz, CDCl3) δ 7.65 – 7.55 (m, 1H), 7.39 (dd, J =
8.3, 0.6 Hz, 1H), 7.23 – 7.16 (m, 3H), 7.11 (dd, J = 8.1, 1.3 Hz,
1H), 7.05 (d, J = 8.7 Hz, 2H), 3.90 (s, 3H). 13C NMR (126 MHz,
CDCl3) δ 160.38 (s), 157.04 (d, J = 2.1 Hz), 156.47 (s), 153.43
(s), 133.98 (s), 129.29 (s), 128.89 (s), 124.79 (s), 124.70 (s),
121.97 (q, J = 275.2 Hz), 119.79 (s), 116.83 (s), 115.14 (q, J =
30.7 Hz), 113.98 (s), 55.38 (s).19F NMR (377 MHz, CDCl3) δ -
57.79 (s). GC–MS (EI, m/z): 320.07.
Ethyl 2-(6-chloro-2-oxo-4-phenyl-2H-chromen-3-yl)-2,2-
difluoro-acetate (7e, CAS: 1699735-64-2)13. White solid (57.1
mg, 73%).1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 1.9 Hz,
1H), 7.30 (dd, J = 6.6, 2.9 Hz, 2H), 7.18 (dd, J = 8.7, 2.0 Hz,
1H), 7.00 (d, J = 8.7 Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.34 (t, J
= 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 162.58 (t, J = 31.1
Hz), 158.40 (t, J = 4.5 Hz), 155.48 (s), 153.32 (s), 139.65 (s),
132.48 (s), 129.73 (s), 129.28 (s), 128.41 (s), 127.53 (s), 125.44
(s), 118.87 (s), 117.99 (t, J = 23.1 Hz), 117.14 (s), 111.68 (t, J =
253.8 Hz), 63.33 (s), 13.80 (s).19F NMR (377 MHz, CDCl3) δ -
98.38 (s). GC–MS (EI, m/z): 378.05.
4-(4-Chlorophenyl)-3-(trifluoromethyl)-2H-chromen-2-one
1
(6h, CAS: 1621190-89-3)12,15. White solid (39.0 mg, 58%). H
NMR (500 MHz, CDCl3) δ 7.68 – 7.61 (m, 1H), 7.53 (d, J = 8.5
Hz, 2H), 7.42 (dd, J = 8.3, 0.9 Hz, 1H), 7.25 – 7.19 (m, 3H), 7.00
(dd, J = 8.1, 1.4 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 156.02
(s), 155.62 (d, J = 2.0 Hz), 153.47 (s), 135.67 (s), 134.34 (s),
131.20 (s), 128.95 (s), 128.77 (s), 128.76 (s), 124.91 (s), 121.75
(q, J = 275.3 Hz), 119.13 (s), 117.00 (s), 115.38 (q, J = 30.1
Hz).19F NMR (377 MHz, CDCl3) δ -57.82 (s). GC–MS (EI, m/z):
324.02.
Ethyl 2-(6-bromo-2-oxo-4-phenyl-2H-chromen-3-yl)-2,2-
difluoroacetate (7f, CAS: 1699735-65-3)13. (54.5 mg, 61%). 1H
NMR (500 MHz, CDCl3) δ 7.58 (d, J = 1.7 Hz, 1H), 7.54 – 7.48
(m, 3H), 7.33 (dd, J = 8.6, 1.8 Hz, 1H), 7.30 (dd, J = 6.5, 2.8 Hz,
2H), 6.92 (d, J = 8.6 Hz, 1H), 4.34 (q, J = 7.1 Hz, 2H), 1.33 (t, J
= 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 162.55 (t, J = 32.1
Hz), 158.30 (t, J = 4.4 Hz), 155.56 (s), 153.19 (s), 132.42 (s),
129.80 (s), 129.29 (s), 128.42 (s), 128.31 (s), 127.79 (s), 127.54
(t, J = 2.2 Hz), 120.10 (s), 119.24 (s), 118.19 (t, J = 23.0 Hz),
111.69 (t, J = 253.7 Hz), 63.33 (s), 13.81 (s). 19F NMR (377
MHz, CDCl3) δ -98.42 (s). GC–MS (EI, m/z): 421.99, 423.99.
Ethyl
2,2-difluoro-2-(2-oxo-4-phenyl-2H-chromen-3-
yl)acetate (7a, CAS: 1699735-60-8)13. White solid (51.0 mg,
1
72%). H NMR (500 MHz, CDCl3) δ 7.61 (t, J = 7.8 Hz, 1H),
7.54 – 7.48 (m, 3H), 7.41 (d, J = 8.3 Hz, 1H), 7.41 (d, J = 8.3 Hz,
1H), 7.32 (dd, J = 6.4, 2.7 Hz, 2H), 7.21 (t, J = 7.7 Hz, 1H), 7.06
(d, J = 8.0 Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz,
3H). 13C NMR (126 MHz, CDCl3) δ 162.73 (t, J = 32.2 Hz),
158.98 (t, J = 4.4 Hz), 156.09 (s), 153.15 (s), 133.46 (s), 132.88
(s), 129.05 (s), 128.79 (s), 128.27 (s), 127.62 (t, J = 2.3 Hz),
124.81 (s), 120.20 (s), 118.05 (t, J = 22.9 Hz), 116.90 (s), 111.81
(t, J = 253.2 Hz), 63.24 (s), 13.82 (s). 19F NMR (377 MHz,
CDCl3) δ -98.34 (s). GC–MS (EI, m/z): 344.09.
Ethyl 2,2-difluoro-2-(4-(4-methoxyphenyl)-6-methyl-2-oxo-
2H-chromen-3-yl)acetate (7g). White solid (54.8 mg, 70%). 1H
NMR (500 MHz, CDCl3) δ 7.60 (t, J = 8.5 Hz, 1H), 7.40 (dd, J =
8.3, 0.7 Hz, 1H), 7.25 (d, J = 8.8 Hz, 2H), 7.24 – 7.20 (m, 1H),
7.16 (dd, J = 8.1, 1.5 Hz, 1H), 7.03 (d, J = 8.7 Hz, 2H), 4.35 (q, J
= 7.1 Hz, 2H), 3.89 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR
(126 MHz, CDCl3) δ 162.83 (t, J = 32.2 Hz), 160.24 (s), 159.12
(t, J = 4.3 Hz), 156.28 (s), 153.15 (s), 133.34 (s), 129.22 (s),
128.82 (s), 124.82 (s), 124.73 (s), 120.48 (s), 118.08 (t, J = 22.6
Hz), 116.90 (s), 113.75 (s), 111.86 (t, J = 253.1 Hz), 63.20 (s),
55.35 (s), 13.82 (s). 19F NMR (377 MHz, CDCl3) δ -98.13 (s). IR
Ethyl
2,2-difluoro-2-(6-methyl-2-oxo-4-phenyl-2H-
chromen-3-yl)acetate (7b, CAS:1699735-61-9)13. White solid
1
(58.1 mg, 78%). H NMR (500 MHz, CDCl3) δ 7.52 – 7.48 (m,
3H), 7.31 (dd, J = 6.6, 2.9 Hz, 2H), 7.21 (s, 1H), 7.02 (dd, J =
8.2, 0.7 Hz, 1H), 6.93 (d, J = 8.2 Hz, 1H), 4.34 (q, J = 7.1 Hz,
2H), 2.46 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz,
CDCl3) δ 162.85 (t, J = 32.3 Hz), 159.26 (t, J = 4.5 Hz), 156.19
(s), 153.24 (s), 145.23 (s), 133.09 (s), 128.96 (s), 128.48 (s),
128.20 (s), 127.61 (t, J = 2.2 Hz), 126.06 (s), 117.80 (s), 116.98